glp-1 digital health news What to Know About the BALANCE Model for GLP-1s in Medicare and Medicaid and the Medicare Bridge Dr. Angela Fitch on GLP-1

Description

Unexpected illnesses, like those requiring antibiotics, are a part of life

GLP-1 (glucagon-like peptide-1) receptor agonists work by helping regulate appetite, slow digestion, and support blood sugar balance

The two main drugs differ: semaglutide (Ozempic, Wegovy) targets GLP-1 receptors only, while tirzepatide (Mounjaro, Zepbound) hits both GIP and GLP-1 receptors which is why clinical trials show tirzepatide producing more weight loss at comparable doses

Nutrients, 2024, DOI: 10.3390/nu16172886, Written by Tarun Sai Lomte Tarun is a writer based in Hyderabad, India

Michael Heim, a board-certified physician in Family Medicine and Osteopathic Manipulation with a certification in Peptide Therapy, Heim Regenerative Medicine Center is committed to empowering every patient to take control of their health journey